{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097059","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.096514+00:00","generated_at":"2026-06-07T10:16:26.447646+00:00","sec_items":["3.02","1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Emmaus exchanges $2.2M in director-held notes for 8.2M shares at $0.29/share","bullets":["Exchanged $1M note from Zen for 3,760,983 shares and $1.2M note from Lim for 4,447,426 shares.","Deemed per-share value of $0.29 represents a premium to Dec 14, 2023 OTCQX closing price.","Zen's note was convertible at $0.50/share, due on demand after Jan 24, 2024; Lim's note due Sep 16, 2025.","Total principal of $2.2M plus accrued interest canceled; no additional cash consideration paid.","Issuance exempt under Section 3(a)(9); directors Zen and Lim are the sole noteholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097059","json":"https://secwatch.observer/filing/0001213900-23-097059.json","markdown":"https://secwatch.observer/filing/0001213900-23-097059.md","text":"https://secwatch.observer/filing/0001213900-23-097059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390023097059/0001213900-23-097059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390023097059/ea190340-8k_emmaus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T10:16:26.447646+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}